NTRP
NextTrip IncNASDAQCONSUMER CYCLICALTRAVEL SERVICES
Key Statistics
Market Cap
$35.82M
P/E Ratio
—
EPS
$-2.22
Beta
1.86
52W High
$5.20
52W Low
$1.72
50-Day MA
$2.90
200-Day MA
$3.47
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About NextTrip Inc
Neurotrope, Inc., a biopharmaceutical company, is focused on developing a product platform for the treatment of Alzheimer's disease. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.18M |
| Gross Profit (TTM) | 413,120 |
| EBITDA | $-12.27M |
| Operating Margin | -257.00% |
| Return on Equity | -681.00% |
| Return on Assets | -84.70% |
| Revenue/Share (TTM) | $0.30 |
| Book Value | $0.47 |
| Price-to-Book | 6.34 |
| Price-to-Sales (TTM) | 16.43 |
| EV/Revenue | 17.89 |
| EV/EBITDA | -0.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1508.00% |
| Shares Outstanding | $13.57M |
| Float | $6.29M |
| % Insiders | 31.39% |
| % Institutions | 8.18% |
Historical Volatility
HV 10-Day
83.67%
HV 20-Day
78.18%
HV 30-Day
107.45%
HV 60-Day
86.35%
HV Rank
57.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($7.83 target)
2
BuyMore CONSUMER CYCLICAL Stocks
Data last updated: 5/5/2026